Effect of quinoline antibiotics on hepatic growth and protein synthesis following partial hepatectomy in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 1, 1997, Pages 54-57

  Minuk, G Y ^a,b   Assy, N ^a   Ding, L X ^a   Gauthier, T ^a   Pashniak, D D ^a  

^a Manitoba Health   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Antimicrobials; Liver; Liver regeneration; Putrescine; Quinolones; aminobutyric acid

Indexed keywords

CIPROFLOXACIN; DNA; FLEROXACIN; NORFLOXACIN; OFLOXACIN; PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; LIVER; LIVER RESECTION; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTI-INFECTIVE AGENTS; DNA; FLUOROQUINOLONES; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0030614788     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00346.x     Document Type: Article

References (21)

1. Gines P, Rimola A, Planas R et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial. Hepatology 1990; 12: 716-24.
2. Cuervas-Mons V, Barrios C, Garrido A et al. Bacterial infections in liver transplant patients under selective decontamination with norfloxacin. Transplant. Proc. 1989; 21: 3558.
3. Soriano G, Guarner C, Tomas A et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-72.
4. Forsgren A, Bredgerg A, Riesbeck K. New quinolones: In vitro effects as a potential source of clinical toxicity. Rev. Infect. Dis. 1989; 11: 1382-9.
5. Esposito S, Galante D, Barba D, Bianchi W, Gagliardi R, Giushi R. Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver disease. Infection 1988; 16 (Suppl. 1): S57-61.
6. Gerding DN, Peterson ALR, Hughes CE, Bangerger DM, Larson TA. Extravascular antimicrobial distribution and the respective blood concentrations in humans In: Lorian V (ed.). P 880-961 Antibiotics in Laboratory Medicine, 3rd edn. Baltimore: Williams and Wilkins. 1991; 942-4.
7. Higgins GM, Anderson RM. Experimental pathology of liver: Restoration of liver of the white rat following partial surgical removal. Arch. Pathol. 1931; 12: 186-202.
8. Luk GD. Essential role of polyamine metabolism in hepatic regeneration. Gastroenterology 1986; 90: 1261-7.
9. Easmon CSF, Crane JP. Uptake of ciprofloxacin by macrophages. J. Clin. Pathol. 1985; 38: 442-4.
10. Hussy P, Maass G, Tummler B, Grosse F, Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase complex, topoisomerase I and II, and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother. 1986; 29: 1073-8.
11. Rusquet R, Bonhommet M, David JC. Quinolone antibiotics inhibit eukaryotic DNA polymerase and terminal deoxynucleotidyl transferase but not DNA ligase. Biochem. Biophys. Res. Commun. 1984; 121: 762-9.
12. Forsgren A, Schlossman SF, Tedder TF. 4-Quinolone drugs affect cycle progression and function of human lymphocytes in vitro. Antimicrob. Agents Chemother. 1987; 31: 768-73.
13. Someth E, Schwartz E, Rubinstein E. The effect of pefloxacin and ciprofloxacin on bone marrow grafting in mice. In: Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. 1987; Abstract 31.
14. Stahlman R, Blankenburg G, Neubert D. Studies on cartilage formation and differentiation in limb-bud culture in the presence of nalidixic acid, ofloxacin and ciprofloxacin. Rev. Infect. Dis. 1988; 10 (Suppl. 1): S147.
15. McQueen CA, Way BM, Queener SM, Schluter G, Williams GM. Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. Toxicol. Appl. Pharmacol. 1991; 111: 255-62.
16. Forsgren A, Bredberg A, Pardee AB, Schlossman SF, Tedder TF. Effects of ciprofloxacin on eukaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrobial. Agents Chemother. 1987; 31: 774-9.
17. 3H]-GABA binding to isolated rat hepatocytes. Am. J. Physiol. 1987; 252: 642-7.
18. Minuk GY, Gauthier T. The effect of gamma aminobutyric acid (GABA) on hepatic regenerative activity following partial hepatectomy in rats. Gastroenterology 1993; 104: 217-21.
19. Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the γ-aminobutyric acid receptor. Antimicrob. Agents Chemother. 1988; 32: 1624-6.
20. Tsuji A, Sato H, Kume Y et al. Inhibitory effects of quinolone antibacterial agents on γ-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob. Agents Chemother. 1988; 32: 190-4.
21. Minuk GY, Gauthier T, Zhang X, Wang GQ, Pettigrew NM, Burczynski FJ. Ciprofloxacin prevents the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat. Hepatology 1995; 22: 1797-800.